Effective Management of Refractory Folliculitis Decalvans Using Secukinumab
DOI:
https://doi.org/10.17140/drmtoj-8-153Keywords:
Folliculitis decalvans, Refractory folliculitis decalvans, SecukinumabAbstract
This case study reports the successful management of a refractory case of folliculitis decalvans in a 40-year-old female patient
using Secukinumab, an interleukin-17A (IL-17A) inhibitor. The patient had a 14-year history of the condition, which had proven
resistant to previous treatments, including topical Betamethasone scalp lotion, Ketoconazole shampoo, and Adalimumab. This
case highlights the potential efficacy of Secukinumab as a therapeutic option for folliculitis decalvans refractory to conventional
treatments.
References
Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, et al. Long-term follow-up of 60 patients in a multicenter series: Therapeutic efficacy and prognostic factors in folliculitis decal-vans. J Am Acad Dermatol. 2018; 79(5): 878-883. doi: 10.1016/j. jaad.2018.05.1240
Otberg N, Kang H, Alzolibani AA, Shapiro J. Folliculitis de-calvans. Dermatol Ther. 2008; 21(4): 238-244. doi: 10.1111/j.1529- 8019.2008.00204.x
Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al. Folliculitis decalvans: A multicentre review of 82 patients. J Eur Acad Dermatol Venereol. 2015; 29(9): 1750-1757. doi: 10.1111/ jdv.12993
Bunagan MJ, Banka N, Shapiro J. A Retrospective examination of 23 patients with folliculitis decalvans: Analysis of disease pro-gression and treatment in prolonged cases. J Cutan Med Surg. 2015; 19(1): 45-49. doi: 10.2310/7750.2014.13218
Tietze JK, Heppt MV, von Preußen A, et al. Comparing vari-ous treatment regimens in 28 patients: Retrospective evaluation of oral isotretinoin’s effectiveness in folliculitis decalvans. J Eur Acad Dermatol Venereol. 2015; 29(9): 1816-1821. doi: 10.1111/jdv.13052
Aksoy B, Hapa A, Mutlu E. A retrospective case-series study on Submit your article to this journal | https://openventio.org/online-manuscript-submission-system/ 7 AlQurashi W, et al the use of isotretinoin in treating folliculitis decalvans. Int J Derma-tol. 2018; 57(2): 250-253. doi: 10.1111/ijd.13874
Collier NJ, Allan D, Diaz Pesantes F, Sheridan L, Allan E. Utili-zation of systemic photodynamic therapy in the treatment of fol-liculitis decalvans. Clinical and Experimental Dermatology. 2018; 43(1): 46-49. doi: 10.1111/ced.13238
Lin X, Zhou S, Wang X, Zhu X. A case report on the use of ami-nolevulinic acid photodynamic therapy in treating folliculitis decal-vans. Dermatol Ther. 2020; 33(3): e13358. doi: 10.1111/dth.13358
Ramonda R, Lorenzin M, Carriero A, et al. Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: A 24-month prospective, multicentre study. RMD Open. 2021; 7(1): e001519. doi: 10.1136/rmdopen-2020-001519
Ismail FF, Sinclair R. Successful treatment of refractory follicu-litis decalvans with secukinumab. Australas J Dermatol. 2020; 61(2): 165-166. doi: 10.1111/ajd.13190 Case Report | Volume 8 | Number 1 |
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Dermatology (DER) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
